FORM OF AMENDMENT AND EXCHANGE AGREEMENTAmendment and Exchange Agreement • March 26th, 2010 • Oxigene Inc • Biological products, (no disgnostic substances)
AMENDMENT AND EXCHANGE AGREEMENT (the “Agreement”) dated as of March 25, 2010, by and among OXiGENE, Inc., a Delaware corporation with offices located at 701 Gateway Blvd, Suite 210, South San Francisco, CA 94080 (the “Company”), and [ ] (the “Investor”).
